05:24 PM EDT, 09/18/2025 (MT Newswires) -- Jasper Therapeutics ( JSPR ) said late Thursday it plans a public offering of common shares as well as pre-funded and common warrants.

Net proceeds will be used to advance the company's development programs of briquilimab in mast-cell driven diseases and for general corporate purposes, according to a statement.

Shares fell 11.5% during after-hours trading.